National Human Genome Research Institute | National Institutes of Health U.S. Department of Health and Human Services |
![]() |
Pathogens and Vectors
Program RationaleGenomic sequencing contributes to our understanding of the molecular basis of human pathogenesis. It offers tremendous potential to direct the discovery of diagnostic targets, drugs and vaccines against parasites, as well as the identification of novel vector control targets. To date, sequencing efforts have only begun to scratch the surface of the vast diversity of organisms that exist; understanding this diversity is crucial to our ability to control infectious diseases. In response to the need for continued efforts in this area and to promote collaborations among scientists and interested funding agencies, the National Human Genome Research Institute (NHGRI) and the National Institute of Allergy and Infectious Diseases (NIAID) have started to coordinate their efforts in the sequencing of human pathogens and vectors of infectious diseases. ![]() Process for Selecting New Pathogen and Vector Sequencing TargetsIn November 2006, NHGRI and NIAID jointly sponsored a workshop (See: NHGRI-NIAID Workshop on Eukaryotic Pathogens and Disease Vectors Sequencing ![]() Approved Sequencing Projects
To view the PDFs on this page you will need Adobe Reader. ![]() Program ContactsLu Wang, Ph.D. Maria Y. Giovanni, Ph.D. Deirdre A. Joy, Ph.D. ![]() Last Reviewed: April 15, 2009 |